VolitionRX Stock News
$0.28
1.11%
today
NYSE,
Jan 06, 09:19 pm CET
Industry
VolitionRX Stock News
Neutral
PRNewsWire
●
20 days ago
HENDERSON, Nev. , Dec. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, issues a Business Review of 2025.
Neutral
PRNewsWire
●
26 days ago
HENDERSON, Nev. , Dec. 11, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces preprint availability of a new manuscript entitled " Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: Measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy ".
Neutral
PRNewsWire
●
29 days ago
HENDERSON, Nev.,, December 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of two abstracts at the North America Conference on Lung Cancer (NACLC) in Chicago recently.
Neutral
PRNewsWire
●
about one month ago
HENDERSON, Nev. , Dec. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the inclusion of its Nu.Q® NETs H3.1 assay in "DETECSEPS", a real-world evaluation of early detection of sepsis.
Neutral
PRNewsWire
●
about one month ago
HENDERSON, Nev. , Nov. 25, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the first sale of its Nu.Q® Cancer assays to one of Europe's leading cancer centers, the Hospices Civils de Lyon, in Lyon, France.
Neutral
Seeking Alpha
●
about 2 months ago
VolitionRx Limited ( VNRX ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Louise Batchelor Day - Group Chief Marketing & Communications Officer Cameron Reynolds - Founder, CEO, President & Director Jacob Micallef - Chief Scientific Officer Terig Hughes - CFO & Treasurer Conference Call Participants Justin Walsh - JonesTrading Institutional Services, LLC, Research Divi...
Neutral
PRNewsWire
●
about 2 months ago
Conference call to discuss financial and operational results scheduled for Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nevada , Nov. 13, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the third quarter ended September 30, 2025.
Neutral
PRNewsWire
●
about 2 months ago
Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
